Analysis of the cluster efficacy and prescription characteristics of traditional Chinese medicine intervention for non-small cell lung cancer based on a clustering algorithm

Author:

Hong Mei1,Sun Wen-Hao2,Lu Ming23,Zhong Tao-Li2,Chen Tian-Yuan2,Zhao Yi-Dong2,Hong Nan2,Zhu Yao2,Ding Yi-Yan4

Affiliation:

1. Department of Radiation Oncology, Nanjing Chest Hospital, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2. Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu, China

3. Nanjing Medical Data Mining Center, Nanjing, Jiangsu, China

4. Department of Traditional Chinese and Western Medicine, Nanjing Chest Hospital, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Abstract

BACKGROUND: In recent years, malignant tumors have gradually become one of the main causes of death for Chinese residents, of which lung cancer ranks first in both the incidence and mortality in China. OBJECTIVE: To mine the text of traditional Chinese medicine (TCM) clinical medical cases after data cleaning, analyze it, and study the experience of TCM doctors in treating non-small cell lung cancer (NSCLC). METHODS: The applied approach was based on the data mining methods of decentralized and hierarchical system clustering of data from a drug and prescription database. This study involved 215 patients, 287 cases, and 147 types of clinical drugs. RESULTS: The data analysis of the clinical treatment of NSCLC in TCM showed that Erchen Decoction was the main method for the treatment of non-small cell lung cancer in clinical treatment of non-small cell lung cancer. Junjian recipes were close to each other, with Banzhilian, Lobelia, Shanci Mushroom, Hedyotis diffusa to anticancer and detoxify. CONCLUSION: This study analyzed the core TCM prescription for NSCLC by collecting the empirical essence and characteristics of specific medications. It has some guiding scientific significance for the clinical treatment of lung cancer.

Publisher

IOS Press

Subject

Health Informatics,Biomedical Engineering,Information Systems,Biomaterials,Bioengineering,Biophysics

Reference11 articles.

1. Lung Cancer Professional Committee of China Anti Cancer Association, Lung Cancer Group of Cancer Branch of Chinese Medical Association. Phase III multi disciplinary expert consensus on diagnosis and treatment of non small cell lung cancer (2019 edition). Chinese Journal of Cancer. 2019; 41(12): 881-890.

2. Solitary pulmonary nodule and (18)F-FDG PET/CT. Part1: Epidemiology, morphological evaluation and cancer probability;Mosmann;Radiol Bras,2016

3. Cancer statistics, 2015;Siegel;CA Cancer J Clin.,2015

4. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin.,2021

5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for the Diagnosis and Treatment of non-Small Cell Lung Cancer of the National Comprehensive Cancer Network (NCCN)-2022 [M]. NCCN Guidelines Version1, 2022, 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3